We are live on ! Find out more
MDXG icon

MiMedx Group

194 hedge funds and large institutions have $580M invested in MiMedx Group in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 63 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.57% more ownership

Funds ownership: 64.27%66.83% (+2.6%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 63

4% less funds holding

Funds holding: 202194 (-8)

12% less capital invested

Capital invested by funds: $657M → $580M (-$77.5M)

25% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 28

88% less call options, than puts

Call options by funds: $56K | Put options by funds: $484K

Holders
194
Holders Change
-8
Holders Change %
-3.96%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
21
Increased
60
Reduced
63
Closed
28
Calls
$56K
Puts
$484K
Net Calls
-$428K
Net Calls Change
-$13K
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$167M
BlackRock
2
BlackRock
New York
$56.8M +$1.94M +293,004 +3%
TI
3
Trigran Investments
Illinois
$45.5M +$21.3M +3,211,623 +72%
Vanguard Group
4
Vanguard Group
Pennsylvania
$41.2M +$283K +42,794 +0.6%
PCMI
5
Paradigm Capital Management Inc
New York
$27.6M +$3.29M +496,900 +12%
State Street
6
State Street
Massachusetts
$22.8M -$714K -107,819 -3%
CC
7
Cannell Capital
Wyoming
$21.3M +$1.84M +277,364 +8%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$16.5M +$293K +44,254 +2%
PAIM
9
Punch & Associates Investment Management
Minnesota
$10.3M +$3.96M +598,430 +52%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$9.24M +$1.8M +271,467 +21%
Renaissance Technologies
11
Renaissance Technologies
New York
$9.01M -$307K -46,355 -3%
Charles Schwab
12
Charles Schwab
California
$8.48M +$614K +92,726 +7%
Morgan Stanley
13
Morgan Stanley
New York
$6.8M -$1.17M -176,862 -13%
Northern Trust
14
Northern Trust
Illinois
$6.36M +$359K +54,121 +5%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$6.35M -$2.76M -416,965 -28%
HCA
16
Harbor Capital Advisors
Illinois
$6.07M +$5.11M +770,744 +300%
RA
17
Royce & Associates
New York
$5.75M +$322K +48,539 +5%
Federated Hermes
18
Federated Hermes
Pennsylvania
$5.36M -$6.14K -927 -0.1%
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$5.29M +$190K +28,724 +3%
RB
20
Richmond Brothers
Michigan
$4.63M -$892K -134,608 -15%
Goldman Sachs
21
Goldman Sachs
New York
$3.88M -$281K -42,401 -6%
Franklin Resources
22
Franklin Resources
California
$3.44M -$124K -18,683 -3%
Millennium Management
23
Millennium Management
New York
$3.41M -$2.07M -312,530 -35%
Bank of America
24
Bank of America
North Carolina
$3.02M +$159K +24,023 +5%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$2.96M +$605K +91,363 +22%

MDXG Hedge Fund Activity: Q3 2024 in Review

194 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q3 2024, worth a combined $580M — down 12% from $657M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of MDXG and 21 opened new positions — a net loss of 7 holders — while 63 trimmed existing stakes and 60 added.

The largest buyer was Trigran Investments, adding an estimated $21.3M. The largest seller was Arrowstreet Capital, cutting an estimated $5.57M.

  • 194 institutional investors held MiMedx Group (MDXG) as of Q3 2024, down from 202 in Q2 2024.
  • Funds reported $580M of MiMedx Group stock for Q3 2024, down 12% quarter-over-quarter.
  • 21 funds opened new MiMedx Group positions in Q3 2024 and 28 closed out, a net change of -7 holders.
  • The largest MiMedx Group buyer in Q3 2024 was Trigran Investments, an estimated $21.3M added.
  • The largest MiMedx Group seller in Q3 2024 was Arrowstreet Capital, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2024.